AVEO PHARMACEUTICALS, INC. Quarterly Return On Assets in % from Q1 2012 to Q3 2022

Taxonomy & unit
ratio: %
Description
Return on assets can be defined as an indicator of how profitable a company is relative to its total assets. Calculated by dividing a company's operating earnings by its total assets.
Summary
Aveo Pharmaceuticals, Inc. quarterly/annual Return On Assets history and growth rate from Q1 2012 to Q3 2022.
  • Aveo Pharmaceuticals, Inc. Return On Assets for the quarter ending September 30, 2022 was -28.8 %, a 47.9% increase year-over-year.
  • Aveo Pharmaceuticals, Inc. annual Return On Assets for 2021 was -46.9 %, a 16.3% increase from 2020.
  • Aveo Pharmaceuticals, Inc. annual Return On Assets for 2020 was -56 %, a 366% decline from 2019.
  • Aveo Pharmaceuticals, Inc. annual Return On Assets for 2019 was 21 %.
Return On Assets, Quarterly (%)
Return On Assets, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Start Date End Date
Q3 2022 -28.8 +26.5 +47.9% Jul 1, 2022 Sep 30, 2022
Q2 2022 -35.2 +23.3 +39.8% Apr 1, 2022 Jun 30, 2022
Q1 2022 -38.9 +18.6 +32.3% Jan 1, 2022 Mar 31, 2022
Q4 2021 -46.9 +9.11 +16.3% Oct 1, 2021 Dec 31, 2021
Q3 2021 -55.3 -7.31 -15.2% Jul 1, 2021 Sep 30, 2021
Q2 2021 -58.5 -51.9 -783% Apr 1, 2021 Jun 30, 2021
Q1 2021 -57.5 -58.5 -6164% Jan 1, 2021 Mar 31, 2021
Q4 2020 -56 -77.1 -366% Oct 1, 2020 Dec 31, 2020
Q3 2020 -48 -140 -152% Jul 1, 2020 Sep 30, 2020
Q2 2020 -6.63 +3.33 +33.5% Apr 1, 2020 Jun 30, 2020
Q1 2020 0.95 -16.6 -94.6% Jan 1, 2020 Mar 31, 2020
Q4 2019 21 +39.9 Oct 1, 2019 Dec 31, 2019
Q3 2019 91.5 +161 Jul 1, 2019 Sep 30, 2019
Q2 2019 -9.95 +61.8 +86.1% Apr 1, 2019 Jun 30, 2019
Q1 2019 17.6 +164 Jan 1, 2019 Mar 31, 2019
Q4 2018 -18.9 +133 +87.6% Oct 1, 2018 Dec 31, 2018
Q3 2018 -69.9 +130 +65.1% Jul 1, 2018 Sep 30, 2018
Q2 2018 -71.7 +77.3 +51.9% Apr 1, 2018 Jun 30, 2018
Q1 2018 -146 -67.3 -85.1% Jan 1, 2018 Mar 31, 2018
Q4 2017 -152 -73 -92.2% Oct 1, 2017 Dec 31, 2017
Q3 2017 -200 -126 -168% Jul 1, 2017 Sep 30, 2017
Q2 2017 -149 -111 -293% Apr 1, 2017 Jun 30, 2017
Q1 2017 -79.1 -47.3 -149% Jan 1, 2017 Mar 31, 2017
Q4 2016 -79.1 -43.5 -122% Oct 1, 2016 Dec 31, 2016
Q3 2016 -74.7 -29.8 -66.1% Jul 1, 2016 Sep 30, 2016
Q2 2016 -37.9 +36.3 +48.9% Apr 1, 2016 Jun 30, 2016
Q1 2016 -31.8 +41.7 +56.8% Jan 1, 2016 Mar 31, 2016
Q4 2015 -35.7 +18.6 +34.2% Oct 1, 2015 Dec 31, 2015
Q3 2015 -45 +2.85 +5.96% Jul 1, 2015 Sep 30, 2015
Q2 2015 -74.3 -25.9 -53.6% Apr 1, 2015 Jun 30, 2015
Q1 2015 -73.5 -22.9 -45.2% Jan 1, 2015 Mar 31, 2015
Q4 2014 -54.2 +4.59 +7.8% Oct 1, 2014 Dec 31, 2014
Q3 2014 -47.8 +8.84 +15.6% Jul 1, 2014 Sep 30, 2014
Q2 2014 -48.3 +7.38 +13.2% Apr 1, 2014 Jun 30, 2014
Q1 2014 -50.6 +0.92 +1.79% Jan 1, 2014 Mar 31, 2014
Q4 2013 -58.8 -9.71 -19.8% Oct 1, 2013 Dec 31, 2013
Q3 2013 -56.7 -10.3 -22.3% Jul 1, 2013 Sep 30, 2013
Q2 2013 -55.7 -15.7 -39.4% Apr 1, 2013 Jun 30, 2013
Q1 2013 -51.5 -22.6 -78.4% Jan 1, 2013 Mar 31, 2013
Q4 2012 -49.1 Oct 1, 2012 Dec 31, 2012
Q3 2012 -46.4 Jul 1, 2012 Sep 30, 2012
Q2 2012 -40 Apr 1, 2012 Jun 30, 2012
Q1 2012 -28.9 Jan 1, 2012 Mar 31, 2012
* An asterisk sign (*) next to the value indicates that the value is likely invalid.